08.13.20

Johnson & Johnson Vision Launches Tecnis Synergy and Tecnis Eyhance IOLs in Canada

Source: Johnson & Johnson Vision

Johnson & Johnson Vision announced Health Canada approval and July availability of its Tecnis Synergy and Tecnis Eyhance IOLs to the Canadian market.

The Tecnis Synergy, originally launched in Europe in September 2019, delivers continuous high-contrast vision from far through near,1 allowing patients to see at their ideal distances, and provide superior low-light contrast benefits from day to night, according to a company news release.2 The Tecnis Eyhance, originally launched in Europe in February 2019, allows patients to experience high-quality vision at both intermediate and far distances.3

The Tecnis Synergy IOL is presbyopia-correcting lens that features optimal defocus curve for clinical performance. The IOL:

  • Gives broad range of continuous vision covering from distance to 33 cm
  • Eliminates the visual gaps present in trifocal and other multifocal technology, offering patients the freedom to focus within the range†† 7,8,9
  • Continues to deliver superior contrast regardless of light conditions†† 2
  • Violet filtering is shown to reduce halo intensity for tasks like night driving, as demonstrated in clinical simulations. Tecnis presbyopia-correcting lens Synergy has an acceptable halo profile.

The Tecnis Eyhance IOL is a next-generation IOL that elevates expectations established by the monofocal category by providing enhanced intermediate vision.3 According to Johnson and Johnson Vision, the Eyhance IOL:

  • Delivers significantly improved intermediate vision, along with 20/20 distance vision3,11
  • Offer a breakthrough refractive design that is progressive in power
  • Feature a low incidence of halo, glare or starbursts (i.e., bright circles of light that surround headlights and other light sources).11

“These new Tecnis lenses are a very promising step forward in the pursuit of more natural vision for our cataract and refractive patients. The ability to provide a more continuous range of vision from near to intermediate and far with the Tecnis Synergy IOL, and provide high monofocal-like safety with improved intermediate vision with the Tecnis Eyhance IOL allows us more choices for our patients,” Ike Ahmed, MD, Assistant Professor and Director of the Glaucoma and Advanced Anterior Surgical Fellowship, University of Toronto, Canada, said in a company news release.

“We’re excited to offer two IOLs to support eye care providers as they return to practice – each meeting a specific unmet need for the cataract patient community,” said Rajesh K. Rajpal, MD, Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision. “Tecnis Synergy IOL is a PC-IOL that delivers continuous high-contrast vision from far through near, day and night, and Tecnis Eyhance defies monofocal conventions to offer intermediate vision, along with the expected distance. Both are built on the strong foundation of the Tecnis Family of IOLs, known for the quality of their optics and outcomes.”

[1] DOF2019OTH4003 – Clinical Investigation of the TECNIS Next-Generation IOL Model ZFR00 (TECNIS Synergy IOL): 6-Month POC Data. 23 Apr 2019.

[1] DOF2019OTH4002 – Weeber H. MTF of the TECNIS Synergy OptiBlue IOL, and other lens models. 27 Mar 2019.

[1] TECNIS Eyhance IOL — Product monograph EMEA 2019, table 4.1 SC2019CT4002.

[1] World Health Organization – Priority Eye Diseases. REF2016OTH0004.

[1] University of Michigan Kellogg Eye Center website. http://www.kellogg.umich.edu/patientcare/conditions/cataract.html. Accessed October 28, 2017. REF2016OTH0327.

[1] TECNIS Synergy IOL DfU– OUS – Doc. #Z311358. Rev. 02, 02/2019. REF2019OTH4259

[1] DOF2019OTH4004 –Perez G. Simulated VA of the TECNIS Synergy IOL and PanOptixIOL. 12 April 2019.

[1] DOF2019OTH4005 –Perez G. Simulated VA of the TECNIS Synergy IOL and AT Lisa Tri IOL. 5 May 2019.

[1] DOF2019OTH4006 –Perez G. Simulated VA of the TECNIS Synergy IOL and FineVisionIOL. 5 May 2019.

[1] Canovas C. et al. Optical and Visual Performance of Violet Blocking Intraocular Lenses. ARVO Poster 2019. SC2019CT4025.

[1] DOF2018CT4015 – Clinical evaluation of the TECNIS Eyhance IOL Model ICB00, 6-month clinical study. Sep. 2018.

[1] American Optometric Association. Presbyopia. American Optometric Association (AOA) Web site: https://www.aoa.org/patients-and-public/eye-and-vision-problems/glossary-of-eye-and-vision-conditions/presbyopia. Accessed July 3, 2019. REF2019CT4316.

Related Content